Epigenetic Modifiers in Myeloid Malignancies: The Role of Histone Deacetylase Inhibitors

Epigenetic Modifiers in Myeloid Malignancies: The Role of Histone Deacetylase Inhibitors

Myeloid hematological malignancies are clonal bone marrow neoplasms, comprising of acute myeloid leukemia (AML), the myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), the myeloproliferative neoplasms (MPN) and systemic mastocytosis (SM). The field of epigenetic regulation of n...

Full description

Bibliographic Details
Main Author: Johanna S. Ungerstedt
Format: Article
Language:English
Published: MDPI AG 2018-10-01
Series:International Journal of Molecular Sciences
Subjects:
myelodysplastic syndromes
acute myeloid leukemia
chronic myelomonocytic leukemia
systemic mastocytosis
treatment
myeloid mutations
Online Access:http://www.mdpi.com/1422-0067/19/10/3091

Internet

http://www.mdpi.com/1422-0067/19/10/3091

Similar Items